Global Drug Addiction Treatment Market Size, Trends and Insights By Type (Opioid Addiction, Benzodiazepine Addiction, Barbiturate Addiction, Others), By Treatment (Therapy, Medication, Others), By Route of Administration (Oral, Parenteral, Others), By End Users (Hospitals, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Medtronic
- Takeda Pharmaceutical Company Limited
- Hoffmann-La Roche Ltd
- Abbott
- BD
- Johnson & Johnson Services Inc.
- Others
Reports Description
Drug Addiction Treatment Market: Overview
The CMI Team’s most recent market research predicts that from 2024 to 2033, the global market for drug addiction treatment will grow at a 7.5% CAGR. In 2023, the market size is projected to reach a valuation of USD 18.6 Billion. By 2033, the valuation is anticipated to reach USD 36.8 Billion.
Patients receiving therapy for substance addiction are those who are unable to manage their cravings. Alcohol, nicotine, and prescription medications have a significant impact on this disorder. Drug addiction impacts not only brain functionality but also affect health and social function. It causes individuals to lose self-control, which then fuels more harmful habits.
When it comes to other medication classes, opioid medicines are less likely to cause addiction quickly and carry a higher risk. The drug addiction market share growth is attributed to several factors such as the rising prevalence of substance use disorders, increasing awareness and acceptance, expansion of insurance coverage, advancements in treatment options and rising government initiatives. However, the lack of awareness and high treatment costs restrict the expansion of the industry during the analysis period.
- As per the data published by the National Center for Drug Abuse Statistics, 309 million Americans aged 12 and older were users of illegal drugs as of 2020.
- 5% of Americans aged 12 and older reported using drugs, a 3.8% rise from the previous year (YoY).
- 277 million or 21.4% of people 12 and over have used illegal substances or misused prescribed medications within the last year.
- 0% of adults over the age of 12 have used illegal substances at some point in their lives, or 138.543 million.
- As per the 2023 National Survey on Drug Use and Health (NSDUH) in the United States
- In 2022, 48.5 million Americans (12 years or older) suffered from substance use disorder.
- In the previous year, 10.2% of Americans aged 12 and over suffered from an alcohol use disorder.
- In the previous year, around 27.2 million Americans aged 12 or older (9.7%) said they had struggled with a drug use issue.
- 5 million (2.7%) Americans aged 12 and over suffered from alcohol and drug use disorders at the same time that year.
- In 2022, 20.4 million Americans have co-occurring disorders, or mental health and drug use disorders.
Drug Addiction Treatment Market: Growth Factors
Advancements in treatment propel the global drug addiction industry
The ongoing development of treatment approaches, such as medications and psychosocial interventions, has a positive impact on the market for drug addiction treatment. Buprenorphine, Narcone, and methadone are the common drugs used in medical-assisted therapies (MAT).
In the treatment of substance use disorders, MAT therapy is very beneficial. Behavioral therapies work better together with digital and personalized treatment to improve patient recovery outcomes. These developments have led to an expansion of the drug addiction treatment market.
Increasing government support influences market revenue
Drug addiction treatment programs are receiving proper support from government authorities across the globe as governments acknowledge addiction as a serious public health issue. Initiatives that lower drug misuse, raise public awareness and improve treatment accessibility.
Through this treatment is more affordable and accessible by a combination of public-private partnerships, regulatory reforms, and financial grants. This kind of public assistance not only makes treatment services more accessible but also fosters ongoing innovation in therapeutic modalities and drives market expansion.
Drug Addiction Treatment Market: Recent Development
The drug addiction treatment industry adopted several strategies, which include product approvals, acquisitions, expansion and others. Some of the company strategies include:
- The U.S. FDA granted Narcan, a 4-milligram (mg) naloxone hydrochloride nasal spray, an OTC license in March 2023, making it the first naloxone medication approved for nonprescription use.
- The US FDA approved RiVive, a 3 mg naloxone hydrochloride nasal spray, for over-the-counter, nonprescription use in situations where treatment of known or suspected opioid overdoses is necessary, in July 2023. With the FDA approval of this second over-the-counter naloxone product, consumers can access this drug without a prescription.
These approvals increased the market significance of the company and capitalize its revenue through its innovative offering.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Drug Addiction Treatment Market | Animal Genetics Market | Smart Orthopedic Implants Market |
| CAGR 7.5% (Approx) | CAGR 5.89% (Approx) | CAGR 5.10% (Approx) |
| USD 36.8 Billion by 2033 | USD 10.88 Billion by 2033 | USD 34.89 Billion by 2033 |
Drug Addiction Treatment Market – Challenge
Reluctance to substance use disorder limits the market
Patients with substance use disorder have a strong resistance, which is one of the primary issues limiting the market’s revenue. As per the data published by the National Survey on Drug Use and Health (NSDUH), over 14% of adults have substance use disorder (12 years or older).
In addition, the evidence that people are reluctant to seek medical assistance due to stigma and reluctance to the impacts of substance use comes from the gradual increase in the number of patients seeking treatment for mental health and other issues.
Drug Addiction Treatment Market: Segment Analysis
By Type:
The opioid addiction type garnered the strongest growth in 2023. The expansion is owing to the several programs by public and private players. Moreover, the growing product approvals favor segment growth.
Besides, the barbiturate addiction segment is expanding at a faster rate during the projected period because it is a life-threatening disorder that needs continuous intervention and treatment.
By Treatment:
The medication segment held the largest revenue share in 2023. The market for opioid addiction treatment has grown overall as a result of the surge in naloxone demand brought on by an increase in opioid overdose rates.
Besides, the therapy segment is expected to grow at a rapid rate over the analysis period. The market is expanding as a result of the growing demand for CBT, which has increased the need for qualified therapists and digital therapy platforms that provide CBT-based programs.
By Route of Administration:
The oral route of administration is expected to capture a prominent market share during the forecast period. The need for methadone is still high due to the growing opioid crisis, especially in North America, which is driving revenue in the oral drug addiction treatment market.
Nevertheless, the parenteral segment is growing at a rapid rate over the analysis period. The demand for Vivitrol has increased due to the growing preference for long-acting injectables over oral drugs taken daily, especially in settings for inpatient and outpatient addiction treatment.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 18.6 Billion |
| Projected Market Size in 2033 | USD 36.8 Billion |
| Market Size in 2023 | USD 17.9 Billion |
| CAGR Growth Rate | 7.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Treatment, Route of Administration, End Users, Distribution Channel and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Drug Addiction Treatment Market – Regional Analysis
North America is projected to lead the market growth during the analysis period. The regional market is anticipated to be driven by the expanding number of people who are susceptible to addiction, well-organized reimbursement systems, the legalization of marijuana in certain states, and improved healthcare sectors.
In the United States, around 17% of people binge drink, and 6% of people are exposed to heavy drinking, according to the CDC. Moreover, nicotine addiction is most frequent in the U.S. with almost 40 million people addicted to tobacco smoking. Therefore, opening up a sizable market for addiction treatment in North America.
However, the Asia Pacific is growing at a significant pace in the global drug addiction treatment industry. This can be attributed to the geographic spread of major actors in Asian nations, as well as the advancement of healthcare infrastructure and government programs that encourage the use of treatment for drug, alcohol, and nicotine addiction.
Competitive Landscape: Drug Addiction Treatment Market
The drug addiction treatment market is highly competitive, with a large number of manufacturers operating globally. Some of the key players in the market include:
- Medtronic
- Takeda Pharmaceutical Company Limited
- Hoffmann-La Roche Ltd
- Abbott
- BD
- Johnson & Johnson Services Inc.
- GSK Plc
- Bayer AG
- Stryker Corporation
- Zimmer Biomet
- Homology Medicines Inc
- Novartis AG
- AVROBIO Inc
- JCR Pharmaceuticals Co. Ltd.
- Sangamo Therapeutics
- Pfizer Inc.
- REGENXBIO Inc
- CANbridge Life Sciences Ltd.
- Denali Therapeutics
- Jasper Therapeutics Inc.
- Others
These companies adopted several strategies such as product launch, product approvals, merger & acquisition and collaboration.
The Global Drug Addiction Treatment Market is segmented as follows:
By Type
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
By Treatment
- Therapy
- Medication
- Others
By Route of Administration
- Oral
- Parenteral
- Others
By End Users
- Hospitals
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Drug Addiction Treatment Market, (2024 – 2033) (USD Million)
- 2.2 Global Drug Addiction Treatment Market: snapshot
- Chapter 3. Global Drug Addiction Treatment Market – Industry Analysis
- 3.1 Drug Addiction Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Advancements in treatment propel the global drug addiction industry
- 3.2.2 Increasing government support influences market revenue.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By End Users
- 3.7.5 Market Attractiveness Analysis By Distribution Channel
- Chapter 4. Global Drug Addiction Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Drug Addiction Treatment Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Drug Addiction Treatment Market: Type Analysis
- 5.1 Global Drug Addiction Treatment Market Overview: By Type
- 5.1.1 Global Drug Addiction Treatment Market Share, By Type, 2023 and 2033
- 5.2 Opioid Addiction
- 5.2.1 Global Drug Addiction Treatment Market by Opioid Addiction, 2024 – 2033 (USD Million)
- 5.3 Benzodiazepine Addiction
- 5.3.1 Global Drug Addiction Treatment Market by Benzodiazepine Addiction, 2024 – 2033 (USD Million)
- 5.4 Barbiturate Addiction
- 5.4.1 Global Drug Addiction Treatment Market by Barbiturate Addiction, 2024 – 2033 (USD Million)
- 5.5 Others
- 5.5.1 Global Drug Addiction Treatment Market by Others, 2024 – 2033 (USD Million)
- 5.1 Global Drug Addiction Treatment Market Overview: By Type
- Chapter 6. Global Drug Addiction Treatment Market: Treatment Analysis
- 6.1 Global Drug Addiction Treatment Market Overview: By Treatment
- 6.1.1 Global Drug Addiction Treatment Market Share, By Treatment, 2023 and 2033
- 6.2 Therapy
- 6.2.1 Global Drug Addiction Treatment Market by Therapy, 2024 – 2033 (USD Million)
- 6.3 Medication
- 6.3.1 Global Drug Addiction Treatment Market by Medication, 2024 – 2033 (USD Million)
- 6.4 Others
- 6.4.1 Global Drug Addiction Treatment Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Drug Addiction Treatment Market Overview: By Treatment
- Chapter 7. Global Drug Addiction Treatment Market: Route of Administration Analysis
- 7.1 Global Drug Addiction Treatment Market Overview: By Route of Administration
- 7.1.1 Global Drug Addiction Treatment Market Share, By Route of Administration, 2023 and 2033
- 7.2 Oral
- 7.2.1 Global Drug Addiction Treatment Market by Oral, 2024 – 2033 (USD Million)
- 7.3 Parenteral
- 7.3.1 Global Drug Addiction Treatment Market by Parenteral, 2024 – 2033 (USD Million)
- 7.4 Others
- 7.4.1 Global Drug Addiction Treatment Market by Others, 2024 – 2033 (USD Million)
- 7.1 Global Drug Addiction Treatment Market Overview: By Route of Administration
- Chapter 8. Global Drug Addiction Treatment Market: End Users Analysis
- 8.1 Global Drug Addiction Treatment Market Overview: By End Users
- 8.1.1 Global Drug Addiction Treatment Market Share, By End Users, 2023 and 2033
- 8.2 Hospitals
- 8.2.1 Global Drug Addiction Treatment Market by Hospitals, 2024 – 2033 (USD Million)
- 8.3 Specialty Clinics
- 8.3.1 Global Drug Addiction Treatment Market by Specialty Clinics, 2024 – 2033 (USD Million)
- 8.4 Others
- 8.4.1 Global Drug Addiction Treatment Market by Others, 2024 – 2033 (USD Million)
- 8.1 Global Drug Addiction Treatment Market Overview: By End Users
- Chapter 9. Global Drug Addiction Treatment Market – Distribution Channel Analysis
- 9.1 Global Drug Addiction Treatment Market Overview: By Distribution Channel
- 9.1.1 Global Drug Addiction Treatment Market Share, By Distribution Channel, 2023 and 2033
- 9.2 Hospital Pharmacy
- 9.2.1 Global Drug Addiction Treatment Market by Hospital Pharmacy, 2024 – 2033 (USD Million)
- 9.3 Retail Pharmacy
- 9.3.1 Global Drug Addiction Treatment Market by Retail Pharmacy, 2024 – 2033 (USD Million)
- 9.4 Online Pharmacies
- 9.4.1 Global Drug Addiction Treatment Market by Online Pharmacies, 2024 – 2033 (USD Million)
- 9.5 Others
- 9.5.1 Global Drug Addiction Treatment Market by Others, 2024 – 2033 (USD Million)
- 9.1 Global Drug Addiction Treatment Market Overview: By Distribution Channel
- Chapter 10. Drugs Addiction Treatment Market: Regional Analysis
- 10.1 Global Drugs Addiction Treatment Market Regional Overview
- 10.2 Global Drugs Addiction Treatment Market Share, by Region, 2023 & 2033 (USD Million)
- 10.3. North America
- 10.3.1 North America Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.3.1.1 North America Drugs Addiction Treatment Market, by Country, 2024 – 2033 (USD Million)
- 10.3.1 North America Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.4 North America Drugs Addiction Treatment Market, by Type, 2024 – 2033
- 10.4.1 North America Drugs Addiction Treatment Market, by Type, 2024 – 2033 (USD Million)
- 10.5 North America Drugs Addiction Treatment Market, by Treatment, 2024 – 2033
- 10.5.1 North America Drugs Addiction Treatment Market, by Treatment, 2024 – 2033 (USD Million)
- 10.6 North America Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033
- 10.6.1 North America Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033 (USD Million)
- 10.7 North America Drugs Addiction Treatment Market, by End Users, 2024 – 2033
- 10.7.1 North America Drugs Addiction Treatment Market, by End Users, 2024 – 2033 (USD Million)
- 10.8 North America Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033
- 10.8.1 North America Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033 (USD Million)
- 10.9. Europe
- 10.9.1 Europe Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.9.1.1 Europe Drugs Addiction Treatment Market, by Country, 2024 – 2033 (USD Million)
- 10.9.1 Europe Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.10 Europe Drugs Addiction Treatment Market, by Type, 2024 – 2033
- 10.10.1 Europe Drugs Addiction Treatment Market, by Type, 2024 – 2033 (USD Million)
- 10.11 Europe Drugs Addiction Treatment Market, by Treatment, 2024 – 2033
- 10.11.1 Europe Drugs Addiction Treatment Market, by Treatment, 2024 – 2033 (USD Million)
- 10.12 Europe Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033
- 10.12.1 Europe Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033 (USD Million)
- 10.13 Europe Drugs Addiction Treatment Market, by End Users, 2024 – 2033
- 10.13.1 Europe Drugs Addiction Treatment Market, by End Users, 2024 – 2033 (USD Million)
- 10.14 Europe Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033
- 10.14.1 Europe Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033 (USD Million)
- 10.15. Asia Pacific
- 10.15.1 Asia Pacific Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.15.1.1 Asia Pacific Drugs Addiction Treatment Market, by Country, 2024 – 2033 (USD Million)
- 10.15.1 Asia Pacific Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.16 Asia Pacific Drugs Addiction Treatment Market, by Type, 2024 – 2033
- 10.16.1 Asia Pacific Drugs Addiction Treatment Market, by Type, 2024 – 2033 (USD Million)
- 10.17 Asia Pacific Drugs Addiction Treatment Market, by Treatment, 2024 – 2033
- 10.17.1 Asia Pacific Drugs Addiction Treatment Market, by Treatment, 2024 – 2033 (USD Million)
- 10.18 Asia Pacific Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033
- 10.18.1 Asia Pacific Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033 (USD Million)
- 10.19 Asia Pacific Drugs Addiction Treatment Market, by End Users, 2024 – 2033
- 10.19.1 Asia Pacific Drugs Addiction Treatment Market, by End Users, 2024 – 2033 (USD Million)
- 10.20 Asia Pacific Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033
- 10.20.1 Asia Pacific Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033 (USD Million)
- 10.21. Latin America
- 10.21.1 Latin America Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.21.1.1 Latin America Drugs Addiction Treatment Market, by Country, 2024 – 2033 (USD Million)
- 10.21.1 Latin America Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.22 Latin America Drugs Addiction Treatment Market, by Type, 2024 – 2033
- 10.22.1 Latin America Drugs Addiction Treatment Market, by Type, 2024 – 2033 (USD Million)
- 10.23 Latin America Drugs Addiction Treatment Market, by Treatment, 2024 – 2033
- 10.23.1 Latin America Drugs Addiction Treatment Market, by Treatment, 2024 – 2033 (USD Million)
- 10.24 Latin America Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033
- 10.24.1 Latin America Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033 (USD Million)
- 10.25 Latin America Drugs Addiction Treatment Market, by End Users, 2024 – 2033
- 10.25.1 Latin America Drugs Addiction Treatment Market, by End Users, 2024 – 2033 (USD Million)
- 10.26 Latin America Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033
- 10.26.1 Latin America Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033 (USD Million)
- 10.27. The Middle-East and Africa
- 10.27.1 The Middle-East and Africa Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.27.1.1 The Middle-East and Africa Drugs Addiction Treatment Market, by Country, 2024 – 2033 (USD Million)
- 10.27.1 The Middle-East and Africa Drugs Addiction Treatment Market, 2024 – 2033 (USD Million)
- 10.28 The Middle-East and Africa Drugs Addiction Treatment Market, by Type, 2024 – 2033
- 10.28.1 The Middle-East and Africa Drugs Addiction Treatment Market, by Type, 2024 – 2033 (USD Million)
- 10.29 The Middle-East and Africa Drugs Addiction Treatment Market, by Treatment, 2024 – 2033
- 10.29.1 The Middle-East and Africa Drugs Addiction Treatment Market, by Treatment, 2024 – 2033 (USD Million)
- 10.30 The Middle-East and Africa Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033
- 10.30.1 The Middle-East and Africa Drugs Addiction Treatment Market, by Route of Administration, 2024 – 2033 (USD Million)
- 10.31 The Middle-East and Africa Drugs Addiction Treatment Market, by End Users, 2024 – 2033
- 10.31.1 The Middle-East and Africa Drugs Addiction Treatment Market, by End Users, 2024 – 2033 (USD Million)
- 10.32 The Middle-East and Africa Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033
- 10.32.1 The Middle-East and Africa Drugs Addiction Treatment Market, by Distribution Channel, 2024 – 2033 (USD Million)
- Chapter 11. Company Profiles
- 11.1 Medtronic
- 11.1.1 Overview
- 11.1.2 Financials
- 11.1.3 Product Portfolio
- 11.1.4 Business Strategy
- 11.1.5 Recent Developments
- 11.2 Takeda Pharmaceutical Company Limited
- 11.2.1 Overview
- 11.2.2 Financials
- 11.2.3 Product Portfolio
- 11.2.4 Business Strategy
- 11.2.5 Recent Developments
- 11.3 F. Hoffmann-La Roche Ltd
- 11.3.1 Overview
- 11.3.2 Financials
- 11.3.3 Product Portfolio
- 11.3.4 Business Strategy
- 11.3.5 Recent Developments
- 11.4 Abbott
- 11.4.1 Overview
- 11.4.2 Financials
- 11.4.3 Product Portfolio
- 11.4.4 Business Strategy
- 11.4.5 Recent Developments
- 11.5 BD
- 11.5.1 Overview
- 11.5.2 Financials
- 11.5.3 Product Portfolio
- 11.5.4 Business Strategy
- 11.5.5 Recent Developments
- 11.6 Johnson & Johnson Services Inc.
- 11.6.1 Overview
- 11.6.2 Financials
- 11.6.3 Product Portfolio
- 11.6.4 Business Strategy
- 11.6.5 Recent Developments
- 11.7 GSK Plc
- 11.7.1 Overview
- 11.7.2 Financials
- 11.7.3 Product Portfolio
- 11.7.4 Business Strategy
- 11.7.5 Recent Developments
- 11.8 Bayer AG
- 11.8.1 Overview
- 11.8.2 Financials
- 11.8.3 Product Portfolio
- 11.8.4 Business Strategy
- 11.8.5 Recent Developments
- 11.9 Stryker Corporation
- 11.9.1 Overview
- 11.9.2 Financials
- 11.9.3 Product Portfolio
- 11.9.4 Business Strategy
- 11.9.5 Recent Developments
- 11.10 Zimmer Biomet
- 11.10.1 Overview
- 11.10.2 Financials
- 11.10.3 Product Portfolio
- 11.10.4 Business Strategy
- 11.10.5 Recent Developments
- 11.11 Homology Medicines Inc
- 11.11.1 Overview
- 11.11.2 Financials
- 11.11.3 Product Portfolio
- 11.11.4 Business Strategy
- 11.11.5 Recent Developments
- 11.12 Novartis AG
- 11.12.1 Overview
- 11.12.2 Financials
- 11.12.3 Product Portfolio
- 11.12.4 Business Strategy
- 11.12.5 Recent Developments
- 11.13 AVROBIO Inc
- 11.13.1 Overview
- 11.13.2 Financials
- 11.13.3 Product Portfolio
- 11.13.4 Business Strategy
- 11.13.5 Recent Developments
- 11.14 JCR Pharmaceuticals Co. Ltd.
- 11.14.1 Overview
- 11.14.2 Financials
- 11.14.3 Product Portfolio
- 11.14.4 Business Strategy
- 11.14.5 Recent Developments
- 11.15 Sangamo Therapeutics
- 11.15.1 Overview
- 11.15.2 Financials
- 11.15.3 Product Portfolio
- 11.15.4 Business Strategy
- 11.15.5 Recent Developments
- 11.16 Pfizer Inc.
- 11.16.1 Overview
- 11.16.2 Financials
- 11.16.3 Product Portfolio
- 11.16.4 Business Strategy
- 11.16.5 Recent Developments
- 11.17 REGENXBIO Inc
- 11.17.1 Overview
- 11.17.2 Financials
- 11.17.3 Product Portfolio
- 11.17.4 Business Strategy
- 11.17.5 Recent Developments
- 11.18 CANbridge Life Sciences Ltd.
- 11.18.1 Overview
- 11.18.2 Financials
- 11.18.3 Product Portfolio
- 11.18.4 Business Strategy
- 11.18.5 Recent Developments
- 11.19 Denali Therapeutics
- 11.19.1 Overview
- 11.19.2 Financials
- 11.19.3 Product Portfolio
- 11.19.4 Business Strategy
- 11.19.5 Recent Developments
- 11.20 Jasper Therapeutics Inc.
- 11.20.1 Overview
- 11.20.2 Financials
- 11.20.3 Product Portfolio
- 11.20.4 Business Strategy
- 11.20.5 Recent Developments
- 11.21 Others.
- 11.21.1 Overview
- 11.21.2 Financials
- 11.21.3 Product Portfolio
- 11.21.4 Business Strategy
- 11.21.5 Recent Developments
- 11.1 Medtronic
List Of Figures
Figures No 1 to 37
List Of Tables
Tables No 1 to 127
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Medtronic
- Takeda Pharmaceutical Company Limited
- Hoffmann-La Roche Ltd
- Abbott
- BD
- Johnson & Johnson Services Inc.
- GSK Plc
- Bayer AG
- Stryker Corporation
- Zimmer Biomet
- Homology Medicines Inc
- Novartis AG
- AVROBIO Inc
- JCR Pharmaceuticals Co. Ltd.
- Sangamo Therapeutics
- Pfizer Inc.
- REGENXBIO Inc
- CANbridge Life Sciences Ltd.
- Denali Therapeutics
- Jasper Therapeutics Inc.
- Others
FAQs
The key factors driving the Market are Advancements in treatment propel the global drug addiction industry, Increasing government support influences market revenue.
The “Opioid Addiction” category dominated the market in 2023.
The key players in the market are Medtronic, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Abbott, BD, Johnson & Johnson Services Inc., GSK Plc, Bayer AG, Stryker Corporation, Zimmer Biomet, Homology Medicines Inc, Novartis AG, AVROBIO Inc, JCR Pharmaceuticals Co. Ltd., Sangamo Therapeutics, Pfizer Inc., REGENXBIO Inc, CANbridge Life Sciences Ltd., Denali Therapeutics, Jasper Therapeutics Inc., Others.
“North America” had the largest share in the Global Drug Addiction Treatment Market.
The global market is projected to grow at a CAGR of 7.5% during the forecast period, 2024-2033.
The Global Drug Addiction Treatment Market size was valued at USD 18.6 Billion in 2024.